Navigation Links
Data mining of inpatient records reveals the disease pattern of obstructive sleep apnea
Date:12/15/2008

Westchester, Ill. A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine is the first to show the full clinical picture of comorbid conditions associated with obstructive sleep apnea (OSA), quantify their frequency of occurrence and reveal their possible interrelationships.

Results show that the number of cases of OSA peaks between the ages of 0-4 years, is low during adolescence, and then rises from 25-29 years to a peak at 55-59 years. The rates are slightly higher for girls than boys in the 0-4 age group (9.4% and 6.7%) and the 5-9 age group (6.0% and 3.9%), and the occurrence rate in males is higher than in females after 20-24 years of age.

According to the study's co-author,Chin Moi Chow , PhD, Senior of health sciences, at the University of Sydney, this study will have a significant impact on the understanding of the disease pattern of OSA and conditions associated with it.

"This research provides a clinical picture of OSA from over six million hospital admissions of all medical conditions and those associated with OSA, and describes its occurrences according to age and gender groups," Chow said.

Findings indicate that OSA patients are high users of health-care services, with comorbid conditions most often involving cardiovascular diseases, endocrine/metabolic diseases (mainly diabetes) and respiratory diseases. Comorbid conditions most frequently appearing with OSA in adults are essential hypertension, obesity, hypercholesterolemia, type 2 diabetes, past or current tobacco use, and ischemic heart conditions.

Data plotting shows that the onset and peak occurrences of obesity and OSA are identical. From obesity onset there is a latent period of five years for the development of hypertension and type 2 diabetes and 15 years for chronic ischemic heart conditions.

A random dataset from the years 1999 through 2004 was extracted using a Health Outcomes and Information Statistical Toolkit. The data set was a representative collection of hospital records in the Inpatient Data Collection System of New South Wales, the most populated Australian state. The data included patient records from 278 public hospitals and 180 private hospitals.

The extracted dataset contained a total of 1.51 million hospital records. Four percent of all records representing 60,197 patients - had a principal or secondary diagnosis of OSA, with a male to female ratio of 2.6:1. The authors report that previous knowledge of disease associations with OSA was fragmented and did not explain possible interrelationships between comorbid diseases. The data mining technique was used to provide the full clinical picture of comorbid conditions associated with OSA.


'/>"/>

Contact: Kelly Wagner
kwagner@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Related medicine news :

1. Gender is key factor in determining overall survival of lung cancer patients
2. Documentary Examining Deadly Blood Disorders and Lifesaving Research to Premiere on Discovery Health
3. Documentary Examining Deadly Blood Disorders and Lifesaving Research to Premiere on Discovery Health
4. Determining Valuations in Challenging Times
5. Senator George Mitchell and the Bipartisan Policy Center to Host Forum Examining Health Insurance Reform
6. Data mining detects signs of Lou Gehrigs disease in gene carriers long before symptoms appear
7. Global Access Project (GAP) Study Examining Patients Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA)
8. Past Earnings Play Role in Determining SSDI Benefits
9. PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
10. Fitness a Key Element in Determining Male Diabetics Longevity
11. Determining genetic signature of lung tumors can help guide treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: